Matthew Baker CEO Antitope |
|
Jacques Descotes Head Lyon Poison Center |
|
Allison Given Senior Scientist Pfizer |
|
Edwin Golez Sr. R & D Associate, Bioanalytical Chemistry Amylin Pharmaceuticals |
|
Thomas-Oliver Kleen Executive VP Immune Monitoring Epiontis |
|
Sanjay Khare CEO and President ImmunGene |
|
Edward T. Maggio President and Chief Executive Officer Aegis Therapeutics |
|
Robin Marsden Scientist II, Bioanalytical Lead Ambrx |
|
Federico Mingozzi Director, Center for Cellular and Molecular Therapeutics Children's Hospital of Philadelphia |
|
Sofie Priem Scientist, Pharmacology-Bioanalytics Ambryx |
|
Priya Sriraman Principal Scientist, Bioanalytics Roche Matthew Baker CEO Antitope | | Jacques Descotes Head Lyon Poison Center | | Allison Given Senior Scientist Pfizer | | Edwin Golez Sr. R & D Associate, Bioanalytical Chemistry Amylin Pharmaceuticals | | Thomas-Oliver Kleen Executive VP Immune Monitoring Epiontis | | Sanjay Khare CEO and President ImmunGene | | Edward T. Maggio President and Chief Executive Officer Aegis Therapeutics | | Robin Marsden Scientist II, Bioanalytical Lead Ambrx | | Federico Mingozzi Director, Center for Cellular and Molecular Therapeutics Children's Hospital of Philadelphia | | Sofie Priem Scientist, Pharmacology-Bioanalytics Ambryx | | Priya Sriraman Principal Scientist, Bioanalytics Roche |
|